Change in PD-L1 and CD8 Expression after Chemoradiotherapy for Esophageal Squamous Cell Carcinoma

Esophageal cancer has a dismal prognosis with a five-year survival rate below 20%. Recently, immunotherapy has become a new standard of care for this cancer; therefore, we aimed to examine the programmed death ligand 1 (PD-L1) expression in esophageal squamous cell carcinoma (ESCC) tissues before an...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wei-Chung, Wu, Chun-Chieh, Chen, Yi-Hsun, Lee, Jui-Ying, Wang, Yao-Kuang, Wu, Nian-Siou, Wu, Ming-Tsang, Wu, I-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405329/
https://www.ncbi.nlm.nih.gov/pubmed/36009434
http://dx.doi.org/10.3390/biomedicines10081888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405329/
https://www.ncbi.nlm.nih.gov/pubmed/36009434
http://dx.doi.org/10.3390/biomedicines10081888

Ejemplares similares